Šalis: Indonezija
kalba: indoneziečių
Šaltinis: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency
SODIUM PHOSPHATE DIBASIC DIHYDRATE; SODIUM PHOSPHATE MONOBASIC
COMBIPHAR - Indonesia
SODIUM PHOSPHATE DIBASIC DIHYDRATE; SODIUM PHOSPHATE MONOBASIC
2,4 G/5 ML; 0,9 G/5 ML
LARUTAN / CAIRAN
DUS, 1 BOTOL PLASTIK @ 45 ML
COMBIPHAR - Indonesia
2019-02-28
COMPOSITION Each dose (45 mL) contains: Sodium dihydrogen phosphate dihydrate 24.4 g; Disodium phosphate dodecahydrate 10.8 g Also includes: Ethanol, sodium benzoate. Sodium content 5.0 g per each 45 mL dose. MODE OF ACTION Phospho-soda produces bowel actions which cleanse the bowel. Phospho-soda acts by osmotic process to increase fluid retention in the lumen of the small intestine. Fluid accumulation in the ileum produces distension and, in turn, promotes peristalsis and bowel evacuation. It usually work within 30 minutes, although it may take as long as six hours. INDICATIONS Phospho-soda is used as part of a bowel cleansing procedure before X-ray of the bowel, colonoscopy (looking into the bowel with an instrument) or before a bowel operation. CONTRAINDICATIONS Phospho-soda is contraindicated: • In children under 15 years (particularly at risk of dehidration). • Patient with faecal impaction, paralytic ileus, bowel obstruction, hypomotility, Hirschsprung’s disease (congenital megacolon), imperforate anus, congestive heart failure, ascites conditions, renal insufficiency and impaired renal function and pre-existing potential fluid/electrolyte disturbance. • Patients at risk of dehydration due to altered senses and/or poor fluid intake. • Patients with known or suspected gastrointestinal obstruction or lack of motility. • Patients with known active inflammatory bowel disease. • Patients when nausea, vomiting or abdominal pain are present. • Patients with known hypersensitivity to active ingredients or any of the excipient. WARNING Serious electrolyte disturbances (hypernatremia, hypokalemia, hyperphosphatemia, hypocalcemia) dehydration, metabolic acidosis, renal failure, tetany and death have been attributed to physicians prescribing more than 45 ml dose (usually a minimum of 90 ml during a 24-hour period) as a bowel preparation for colonoscopy, surgery or barium enema and/or prescribing it for people at medical risk. PRECAUTIONS Phospho-soda should be used with extreme caution in the elderly, i Perskaitykite visą dokumentą